RFC
NVAX icon

Russell Frank Company’s Novavax NVAX Stock Holding History

Russell Frank Company’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-580
Closed -$97K – 3012
2015
Q4 		$97K Sell
580
-1,941
-77% -$299K ﹤0.01% 2806
2015
Q3 		$356K Sell
2,521
-5,664
-69% -$1.27M ﹤0.01% 2579
2015
Q2 		$1.82M Sell
8,185
-1,855
-18% -$326K ﹤0.01% 2025
2015
Q1 		$1.66M Sell
10,040
-8,441
-46% -$1.37M ﹤0.01% 1888
2014
Q4 		$2.15M Buy
18,481
+2,239
+14% +$234K ﹤0.01% 1750
2014
Q3 		$1.35M Sell
16,242
-1,935
-11% -$175K ﹤0.01% 1920
2014
Q2 		$1.58M Buy
18,177
+336
+2% +$29.5K ﹤0.01% 1863
2014
Q1 		$1.62M Buy
17,841
+520
+3% +$58.1K ﹤0.01% 1870
2013
Q4 		$1.93M Buy
17,321
+6,651
+62% +$470K ﹤0.01% 1743
2013
Q3 		$675K Buy
10,670
+10,312
+2,880% +$581K ﹤0.01% 2371
2013
Q2 		$15K Buy
+358
New +$15.5K ﹤0.01% 3035

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Russell Frank Company's NVAX Position: Q1 2016 in Review

Russell Frank Company sold out of Novavax (NVAX) in Q1 2016, closing a stake of 580 shares — an estimated $97K sold.

Russell Frank Company first reported a position in NVAX in Q2 2013 and held it in 11 quarters. The position peaked at $2.15M in Q4 2014. 175 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • Russell Frank Company reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • Russell Frank Company sold 580 Novavax shares in Q1 2016, an estimated $97K.
  • Russell Frank Company first reported a position in Novavax in Q2 2013 and held it in 11 quarters.
  • Russell Frank Company's Novavax position peaked at $2.15M in Q4 2014.
  • 175 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.